1-8 of 8
atrial fibrillation
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry

Clinical Trials & Observations
Jean-Pierre Bassand, Saverio Virdone, Marc Badoz, Freek W. A. Verheugt, A. John Camm, Frank Cools, Keith A. A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, Frank Misselwitz, Karen S. Pieper, Alexander G. G. Turpie, Martin van Eickels, Ajay K. Kakkar
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1081–1091.
https://doi.org/10.1182/bloodadvances.2020003560
Published: 2021
Includes: Supplemental data
Journal Articles

Outcomes associated with apixaban vs warfarin in patients with renal dysfunction

Clinical Trials & Observations
Claudia Hanni, Elizabeth Petrovitch, Mona Ali, Whitney Gibson, Christopher Giuliano, Jenna Holzhausen, Charles Makowski, Amy Pallisco, Nisha Patel, Denise Sutter, Long To, Raymond Yost
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2366–2371.
https://doi.org/10.1182/bloodadvances.2019000972
Published: 2020
Journal Articles

Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies

Clinical Trials & Observations
Steven E. Coutre, John C. Byrd, Peter Hillmen, Jacqueline C. Barrientos, Paul M. Barr, Stephen Devereux, Tadeusz Robak, Thomas J. Kipps, Anna Schuh, Carol Moreno, Richard R. Furman, Jan A. Burger, Michael O’Dwyer, Paolo Ghia, Rudolph Valentino, Stephen Chang, James P. Dean, Danelle F. James, Susan M. O’Brien
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1799–1807.
https://doi.org/10.1182/bloodadvances.2018028761
Published: 2019
Includes: Supplemental data
Journal Articles

Comment on model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients

Clinical Trials & Observations
Stefan Willmann, Liping Zhang, Hannah Mayer, Hans-Ulrich Siegmund, Takahiko Tanigawa, Masato Kaneko, Gary Peters, Jeffrey I. Weitz, Scott D. Berkowitz, Rolf Burghaus
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3193–3195.
https://doi.org/10.1182/bloodadvances.2018027078
Published: 2018
Journal Articles

Model-based meta-analysis to evaluate optimal doses of direct oral factor Xa inhibitors in atrial fibrillation patients

Clinical Trials & Observations
Hideki Yoshioka, Hiromi Sato, Hiroto Hatakeyama, Akihiro Hisaka
Journal: Blood Advances
Blood Adv (2018) 2 (10): 1066–1075.
https://doi.org/10.1182/bloodadvances.2017013805
Published: 2018
Includes: Supplemental data
Journal Articles

Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation

Clinical Trials & Observations
Surbhi Shah, Faye L. Norby, Yvonne H. Datta, Pamela L. Lutsey, Richard F. MacLehose, Lin Y. Chen, Alvaro Alonso
Journal: Blood Advances
Blood Adv (2018) 2 (3): 200–209.
https://doi.org/10.1182/bloodadvances.2017010694
Published: 2018
Includes: Supplemental data
Journal Articles

Sociodemographic factors in patients continuing warfarin vs those transitioning to direct oral anticoagulants

Clinical Trials & Observations
Jordan K. Schaefer, Suman L. Sood, Brian Haymart, Xiaokui Gu, Xiaowen Kong, Eva Kline-Rogers, Steven Almany, Jay Kozlowski, Gregory D. Krol, Scott Kaatz, James B. Froehlich, Geoffrey D. Barnes
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2536–2540.
https://doi.org/10.1182/bloodadvances.2017012377
Published: 2017
Journal Articles

Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib

Clinical Trials & Observations
Tracy E. Wiczer, Lauren B. Levine, Jessica Brumbaugh, Jessica Coggins, Qiuhong Zhao, Amy S. Ruppert, Kerry Rogers, Anli McCoy, Luay Mousa, Avirup Guha, Nyla A. Heerema, Kami Maddocks, Beth Christian, Leslie A. Andritsos, Samantha Jaglowski, Steven Devine, Robert Baiocchi, Jennifer Woyach, Jeffrey Jones, Michael Grever, Kristie A. Blum, John C. Byrd, Farrukh T. Awan
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1739–1748.
https://doi.org/10.1182/bloodadvances.2017009720
Published: 2017
Includes: Supplemental data